Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/02/2022* -- Results Q1 2023 -- 1.83 --
11/02/2022* 08:00 EST Earnings Call Q1 2023 -- -- --
08/04/2022 -- Results Q4 2022 2.05 2.08 -1.30%
08/04/2022 09:00 EST Earnings Call Q4 2022 -- -- --
05/04/2022 -- Results Q3 2022 2.14 2.00 7.15%
05/04/2022 08:00 EST Earnings Call Q3 2022 -- -- --
02/01/2022 -- Results Q2 2022 1.88 1.79 5.11%
02/01/2022 09:00 EST Earnings Call Q2 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/02/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/04/2022
Beat/Miss Upgrade
Return Since -25.84%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
URL https://www.bio-techne.com
Investor Relations URL https://investors.bio-techne.com/
HQ State/Province Minnesota
Sector Healthcare
Industry Biotechnology
Equity Style Mid Cap/Growth
Next Earnings Release Nov. 02, 2022 (est.)
Last Earnings Release Aug. 04, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 12, 2022

Dividends

Dividend Per Share (TTM) 1.28
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.3088
Yield to Sector 0.2381
Yield to Industry 0.6028
Last Dividend Amt. 0.32
Dividend Frequency Quarterly
Last Ex-Dividend Date Aug. 12, 2022
Yield (TTM) 0.45%
Forward Yield 0.44%
Payout Ratio 18.45%
Cash Payout Ratio 17.90%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-1.30%
15.75%
27.41%
12.61%
52.67%
45.39%
63.39%
-43.87%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-21.05%
41.48%
-84.98%
-1.59%
48.39%
-89.18%
2.70K%
28.30%
-86.29%
39.68%
17.58%
1.38%
5.91%
101.7%
53.28%
-11.73%
-10.92%
-67.80%
-28.59%
-49.84%
-47.69%
-93.17%
229.0%
-48.60%
-35.80%
-44.57%
-56.37%
48.58%
-52.96%
5.47%
10.67%
-77.09%
28.89%
As of September 28, 2022.

Profile

Edit
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
URL https://www.bio-techne.com
Investor Relations URL https://investors.bio-techne.com/
HQ State/Province Minnesota
Sector Healthcare
Industry Biotechnology
Equity Style Mid Cap/Growth
Next Earnings Release Nov. 02, 2022 (est.)
Last Earnings Release Aug. 04, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 12, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
BGRUX 277.31M USD 4.28%
BCSIX 156.28M USD 3.98%
FBT 37.30M USD 2.92%
BIGZ 64.17M USD 2.86%
BBH 10.54M USD 2.60%
NBGAX 231.33M USD 2.46%
CMGSX 407.34M USD 2.38%
IBB 83.31M USD 1.15%
VISGX 195.77M USD 0.68%
VBK 195.77M USD 0.68%
NAESX 330.35M USD 0.28%
VB 330.35M USD 0.28%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter TECH Tweets